Bayer reports positive Phase III FIND-CKD results for Kerendia in non-diabetic chronic kidney disease

Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline

Lupin's Ranluspec (ranibizumab) injection receives US FDA approval

Pharming secures FDA acceptance of Joenja filing for children with APDS

ADC Therapeutics reports trial results for ZYNLONTA - rituximab combination in relapsed or refractory diffuse large B-Cell lymphoma

Medtronic seeks expanded US approvals for Hugo robotic surgery system

MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors

Lupin and Natco secure US FDA approval for generic Eribulin Mesylate Injection

Luminopia agrees international licensing deal for paediatric amblyopia treatment in Japan

FDA accepts Genentech's giredestrant application for early-stage breast cancer

Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC

Haisco receives US FDA approval for anaesthetic Cipepofol

Hanmi signs licensing deal with Lilly for sonefpeglutide

FDA approves TREMFYA label expansion

GSK reports positive phase III data for bepirovirsen in chronic hepatitis B